Dr. Martens plc (DOCSL.XC)
- Previous Close
80.95 - Open
80.70 - Bid 79.20 x --
- Ask 79.35 x --
- Day's Range
78.68 - 80.70 - 52 Week Range
45.00 - 88.00 - Volume
720,003 - Avg. Volume
358,810 - Market Cap (intraday)
761.469M - Beta (5Y Monthly) 0.15
- PE Ratio (TTM)
7,895.00 - EPS (TTM)
0.01 - Earnings Date Jun 5, 2025
- Forward Dividend & Yield 0.03 (3.27%)
- Ex-Dividend Date Aug 28, 2025
- 1y Target Est
--
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company was founded in 1945 and is based in London, the United Kingdom.
www.drmartensplc.com2,348
Full Time Employees
March 30
Fiscal Year Ends
Sector
Industry
Recent News: DOCSL.XC
View MorePerformance Overview: DOCSL.XC
Trailing total returns as of 6/11/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DOCSL.XC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DOCSL.XC
View MoreValuation Measures
Market Cap
781.72M
Enterprise Value
1.03B
Trailing P/E
155.85
Forward P/E
18.12
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.96
Price/Book (mrq)
2.05
Enterprise Value/Revenue
1.26
Enterprise Value/EBITDA
9.01
Financial Highlights
Profitability and Income Statement
Profit Margin
0.57%
Return on Assets (ttm)
4.12%
Return on Equity (ttm)
1.23%
Revenue (ttm)
787.6M
Net Income Avi to Common (ttm)
4.5M
Diluted EPS (ttm)
0.01
Balance Sheet and Cash Flow
Total Cash (mrq)
155.9M
Total Debt/Equity (mrq)
110.29%
Levered Free Cash Flow (ttm)
164.56M